DescriptionUnder the direction from the Program Coordinator, the candidate applies his/her technical expertise in the field of cellular and molecular immunology and cancer biology. This candidate will be working for Therapeutic Tumor Microenvironment Strategies NewCo2, a UPMC Enterprises funded biotech startup.
Master’s Degree (MS) from an accredited institution with
3+ years of experience in immunology or a Bachelor’s Degree
from an accredited institution with 6+ years of experience in immunology
· Strong and direct prior experience with several of the following relevant techniques:
Cellular and/or molecular immunology or oncology
Microscopy and cellular characterization of samples (incl. quantitative imaging
o Flow cytometry and cell sorting Molecular biology techniques (e.g., PCR, development of genetic constructs, cloning, etc.) NGS (WGS, WES or RNAseq, including preparation of genomic libraries) CRISPR or other advanced genetic editing techniques
o Use of mouse cancer models Processing and characterization of fresh human tumor samples Cell-based metabolic assays
o Ability to propose new experimental designs, plan and conduct laboratory experiments, and evaluate and interpret data
o Fundamental understanding of the process of discovery and development of immunology-based therapeutic targets and possible novel therapeutic concepts
o Critical thinking e.g. by proposing and implementing novel experimental approaches and concepts contributing to the cancer immunology and immune therapy research goals
o Product and goal oriented, focused on a career in biotech.
o Highly efficient and organized and have a demonstrated ability to adhere to and follow defined timelines, milestone, and objectives
Licensure, Certifications, and Clearances:UPMC is an equal opportunity employer. Minority/Females/Veterans/Individuals with Disabilities